Skip to main content

Ondansetron (International)

In the US, Ondansetron (ondansetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Alcohol Use Disorder, Gastroenteritis, Nausea/Vomiting, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative, Nausea/Vomiting - Radiation Induced, Obsessive Compulsive Disorder, Postanesthetic Shivering and Pruritus.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A04AA01

CAS registry number (Chemical Abstracts Service)

0099614-02-5

Chemical Formula

C18-H19-N3-O

Molecular Weight

293

Therapeutic Categories

Antiemetic agent

Serotonin 5HT₃-receptor antagonist

Chemical Names

(+-)-2,3-dihydro-9-metyl-3-[(2-metylimidazol-1-yl)metyl]carbazol-4(1H)-one (WHO)

4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-metyl-3-[(2-metyl-1H-imidazol-1-yl)metyl]-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs